(BPT) - As the world looks with hope to the light at the end of the COVID-19 tunnel, there lies another ongoing health crisis that, according to the American Heart Association (AHA), kills more Americans than anything else: heart disease. In the last year, heart disease claimed more than 690,000 lives in the U.S., which is staggeringly more than the reported 345,000 lives lost to COVID-19, according to data from the Centers for Disease Control and Prevention. With the prevalence of this disease and the large amount of clinical data surrounding the management of CV risk factors, one would assume that the approaches used to reduce the risk of a CV event, such as a heart attack or stroke, would be standard practice Continue reading →

Nanomedicine-Market Latest research on Global Nanomedicine Market report covers forecast and analysis on a worldwide, regional and country level. The study provides historical information of 2016-2021 together with a forecast from 2021 to 2026 supported by both volume and revenue (USD million) Continue reading →

Patients with cardiovascular disease who are under added strain due to sociodemographic factors, such as financial instability and food insecurity, are less likely to take steps to protect themselves from COVID-19 and less able to avoid situations, like crowded work or living spaces, that carry the risk of exposure to SARS-CoV-2. The results, from a survey of US adults during the pandemics first wave, are set to be presented at the virtual American College of Cardiology (ACC) 2021 Scientific Session later this month and are now published in Circulation: Cardiovascular Quality and Outcomes. Prior studies have shown that social determinants of health (SDOH) have an additive effect on cardiovascular health, a risk that persists even when accounting for more-traditional markers like comorbidities and smoking Continue reading →